Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stephens

Showing results (811-820 of 853) with videos related to

Pageof 86
Sort By:
Frontiers in Neurology|June 18, 2020
Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early StagesSuzanne M Shdo, Kamalini G Ranasinghe, Virginia E Sturm, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 5, 2023
FeNC Oxygen Reduction Electrocatalyst with High Utilization Penta-Coordinated SitesJesús Barrio, Angus Pedersen, Saurav Ch Sarma, et al.
Nature Chemistry|July 24, 2014
Mass-selected nanoparticles of PtxY as model catalysts for oxygen electroreductionPatricia Hernandez-Fernandez, Federico Masini, David N McCarthy, et al.
Nature Communications|January 23, 2021
Global patterns and climatic controls of forest structural complexityMartin Ehbrecht, Dominik Seidel, Peter Annighöfer, et al.
Archives of Toxicology|May 15, 2017
A primer on systematic reviews in toxicologySebastian Hoffmann, Rob B M de Vries, Martin L Stephens, et al.
The Lancet. HIV|December 18, 2018
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trialJoseph J Eron, Jean-Daniel Lelievre, Robert Kalayjian, et al.
Lab Animal|September 1, 2006
Report of the Working Group on Animal Distress in the LaboratoryMarilyn Brown, Larry Carbone, Kathleen M Conlee, et al.
Annals of Clinical and Translational Neurology|January 19, 2022
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19Alexandra C Apple, Alexis Oddi, Michael J Peluso, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Journal of Neurovirology|February 2, 2021
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patientsJoanna Hellmuth, T Allen Barnett, Breton M Asken, et al.
Pageof 86

Showing results (811-820 of 853) with videos related to

Sort By:
Pageof 86
Frontiers in Neurology|June 18, 2020
Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early StagesSuzanne M Shdo, Kamalini G Ranasinghe, Virginia E Sturm, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 5, 2023
FeNC Oxygen Reduction Electrocatalyst with High Utilization Penta-Coordinated SitesJesús Barrio, Angus Pedersen, Saurav Ch Sarma, et al.
Nature Chemistry|July 24, 2014
Mass-selected nanoparticles of PtxY as model catalysts for oxygen electroreductionPatricia Hernandez-Fernandez, Federico Masini, David N McCarthy, et al.
Nature Communications|January 23, 2021
Global patterns and climatic controls of forest structural complexityMartin Ehbrecht, Dominik Seidel, Peter Annighöfer, et al.
Archives of Toxicology|May 15, 2017
A primer on systematic reviews in toxicologySebastian Hoffmann, Rob B M de Vries, Martin L Stephens, et al.
The Lancet. HIV|December 18, 2018
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trialJoseph J Eron, Jean-Daniel Lelievre, Robert Kalayjian, et al.
Lab Animal|September 1, 2006
Report of the Working Group on Animal Distress in the LaboratoryMarilyn Brown, Larry Carbone, Kathleen M Conlee, et al.
Annals of Clinical and Translational Neurology|January 19, 2022
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19Alexandra C Apple, Alexis Oddi, Michael J Peluso, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Journal of Neurovirology|February 2, 2021
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patientsJoanna Hellmuth, T Allen Barnett, Breton M Asken, et al.
Pageof 86